Lyon Street Capital’s GoodRx Holdings GDRX Stock Holding History

Lyon Street Capital’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$464K	Buy	+24,000	New	+$550K	0.69%	73

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return

RRCP

Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Lyon Street Capital's GDRX Position: Q1 2022 in Review

Lyon Street Capital opened a new position in GoodRx Holdings (GDRX) in Q1 2022: 24,000 shares worth $464K. The stake represents 0.69% of the portfolio and ranks #73 among its holdings.

167 funds tracked by Wall St. Rank hold GDRX as of Q1 2022.

Lyon Street Capital held 24,000 shares of GoodRx Holdings worth $464K as of Q1 2022.
GoodRx Holdings was a new Lyon Street Capital position in Q1 2022.
GoodRx Holdings made up 0.69% of Lyon Street Capital's portfolio in Q1 2022, its #73 holding.
167 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2022.

Based on Lyon Street Capital's 13F filing for Q1 2022, filed 16 May 2022.